1303109009: Product containing ertugliflozin and sitagliptin in oral dose form (medicinal product form)

• SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\Product containing sodium glucose cotransporter subtype 2 inhibitor (product)\Product containing ertugliflozin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Medicinal product categorized by disposition (product)\Product containing sodium glucose cotransporter subtype 2 inhibitor (product)\Product containing ertugliflozin (medicinal product)\Product containing ertugliflozin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing hydrolase inhibitor (product)\Product containing peptide hydrolase inhibitor (product)\Product containing proteinase inhibitor (product)\Product containing serine proteinase inhibitor (product)\Product containing sitagliptin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing hydrolase inhibitor (product)\Product containing peptide hydrolase inhibitor (product)\Product containing proteinase inhibitor (product)\Product containing serine proteinase inhibitor (product)\Product containing sitagliptin (medicinal product)\Product containing sitagliptin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing hydrolase inhibitor (product)\Product containing peptide hydrolase inhibitor (product)\Product containing dipeptidyl peptidase IV inhibitor (product)\Product containing sitagliptin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing hydrolase inhibitor (product)\Product containing peptide hydrolase inhibitor (product)\Product containing dipeptidyl peptidase IV inhibitor (product)\Product containing sitagliptin (medicinal product)\Product containing sitagliptin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing azole (product)\Product containing sitagliptin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing azole (product)\Product containing sitagliptin (medicinal product)\Product containing sitagliptin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Medicinal product categorized by structure\Product containing ertugliflozin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Medicinal product categorized by structure\Product containing ertugliflozin (medicinal product)\Product containing ertugliflozin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Product manufactured as oral dose form (product)\Product containing sitagliptin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
• \Product manufactured as oral dose form (product)\Product containing ertugliflozin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5304784015	Ertugliflozin- and sitagliptin-containing product in oral dose form	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5304785019	Product containing ertugliflozin and sitagliptin in oral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start